| Size | Price | Stock | Qty |
|---|---|---|---|
| 1mg |
|
||
| Other Sizes |
| Targets |
N-Benzylpentadecanamide does not have a specific, well-defined molecular target. As a natural product from Maca, it is studied for its potential biological activities. Macamides are known to interact with various targets, including fatty acid amide hydrolase (FAAH) and cannabinoid receptors, but the specific target of this compound is not identified in the provided literature.
|
|---|---|
| ln Vitro |
Specific in vitro biological activity data for N-Benzylpentadecanamide are not reported in the provided literature. As a macamide, it is part of a class of compounds studied for their potential effects on the endocannabinoid system and other pathways, but specific potency data for this compound are not provided.
|
| ln Vivo |
Specific in vivo data for N-Benzylpentadecanamide are not reported. As a research compound, it may be used in animal studies to investigate the pharmacological effects of Maca extracts, but such studies are not detailed in the search results.
|
| Enzyme Assay |
No specific biochemical assay protocols for N-Benzylpentadecanamide are detailed. To study its activity, it could be used in enzyme activity assays, such as those measuring FAAH inhibition, or in receptor binding assays. Its characterization is performed using standard analytical techniques like HPLC, NMR, and MS.
|
| Cell Assay |
In cellular studies, N-Benzylpentadecanamide would be used to investigate its effects on cell signaling pathways. It is typically dissolved in a suitable solvent like DMSO and applied to cultured cells. Standard assays such as cell viability, proliferation, or specific signaling readouts (e.g., cAMP levels) would be used.
|
| Animal Protocol |
In vivo studies for N-Benzylpentadecanamide would be conducted in animal models to investigate the effects of Maca constituents. The compound would likely be administered orally or intraperitoneally. Endpoints would depend on the research focus, such as effects on behavior, metabolism, or reproductive function.
|
| ADME/Pharmacokinetics |
Specific pharmacokinetic (PK) data for N-Benzylpentadecanamide are not reported. The compound is a small, lipophilic molecule (MW 331.54), which suggests it may have good oral bioavailability and the potential to cross the blood-brain barrier. It is a white to off-white solid and is typically stored at -20°C.
|
| Toxicity/Toxicokinetics |
Specific toxicological data for N-Benzylpentadecanamide are not reported. As a natural product, it is generally considered to have a moderate safety profile, but comprehensive toxicology studies have not been published. It is for research use only.
|
| References | |
| Additional Infomation |
N-benzylpentadecanamide has been reportedly found in Lepidium meyenii, and relevant data are available for reference.
N-Benzylpentadecanamide is a natural N-benzylamide found in Maca (Lepidium meyenii). It has the molecular formula C22H37NO and a molecular weight of 331.54. It is used as a research tool to study the bioactive constituents of Maca. It has no clinical applications and is for research use only. |
| Molecular Formula |
C22H37NO
|
|---|---|
| Molecular Weight |
331.53500
|
| Exact Mass |
331.287
|
| CAS # |
1572037-13-8
|
| PubChem CID |
102326455
|
| Appearance |
White to off-white solid
|
| LogP |
7.8
|
| Hydrogen Bond Donor Count |
1
|
| Hydrogen Bond Acceptor Count |
1
|
| Rotatable Bond Count |
15
|
| Heavy Atom Count |
24
|
| Complexity |
284
|
| Defined Atom Stereocenter Count |
0
|
| SMILES |
CCCCCCCCCCCCCCC(=O)NCC1=CC=CC=C1
|
| InChi Key |
CBYQHFBHSMAGBU-UHFFFAOYSA-N
|
| InChi Code |
InChI=1S/C22H37NO/c1-2-3-4-5-6-7-8-9-10-11-12-16-19-22(24)23-20-21-17-14-13-15-18-21/h13-15,17-18H,2-12,16,19-20H2,1H3,(H,23,24)
|
| Chemical Name |
N-Benzylpentadecanamide
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
|
|---|---|
| Solubility (In Vivo) |
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.
Injection Formulations
Injection Formulation 1: DMSO : Tween 80： Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)(e.g. IP/IV/IM/SC) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 ：Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). View More
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). View More
Oral Formulation 3: Dissolved in PEG400 (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 3.0162 mL | 15.0811 mL | 30.1623 mL | |
| 5 mM | 0.6032 mL | 3.0162 mL | 6.0325 mL | |
| 10 mM | 0.3016 mL | 1.5081 mL | 3.0162 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
